Mirum Pharmaceuticals, Inc.
MIRM
$43.42
-$0.03-0.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.79M | -14.24M | -24.64M | -25.28M | -35.66M |
| Total Depreciation and Amortization | 6.43M | 6.46M | 6.44M | 5.66M | 5.64M |
| Total Amortization of Deferred Charges | 416.00K | 424.00K | 407.00K | 414.00K | 399.00K |
| Total Other Non-Cash Items | 13.56M | 8.01M | 14.78M | 12.68M | 20.45M |
| Change in Net Operating Assets | -1.68M | 3.33M | -794.00K | 21.73M | -7.45M |
| Cash from Operations | -5.07M | 3.98M | -3.80M | 15.21M | -16.62M |
| Capital Expenditure | -20.00K | -181.00K | -779.00K | -13.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 661.00K | -17.86M | -71.94M | -- | -2.00M |
| Cash from Investing | 641.00K | -18.04M | -72.72M | -13.00K | -2.00M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.34M | 3.86M | 7.29M | 1.21M | 2.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -281.00K |
| Cash from Financing | 5.34M | 3.86M | 7.29M | 1.21M | 1.78M |
| Foreign Exchange rate Adjustments | -1.38M | 88.00K | -119.00K | 113.00K | 108.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -466.00K | -10.10M | -69.35M | 16.52M | -16.73M |